Hochmair, M., Schenker, M., Cobo Dols, M., Kim, T. M., Ozyilkan, O., Smagina, M., . . . Nadal, E. (2025). Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous Non–Small-Cell Lung Cancer That Responded to First-Line Pembrolizumab Plus Chemotherapy.
Citación estilo ChicagoHochmair, Maximilian, et al. Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous Non–Small-Cell Lung Cancer That Responded to First-Line Pembrolizumab Plus Chemotherapy. 2025.
Cita MLAHochmair, Maximilian, et al. Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous Non–Small-Cell Lung Cancer That Responded to First-Line Pembrolizumab Plus Chemotherapy. 2025.
Precaución: Estas citas no son 100% exactas.